The DOI matches its OpenAlex record; 61 of the 61 references it cites were found in a registry or an index.
The Partial Agonist Activity of Antagonist-Occupied Steroid Receptors Is Controlled by a Novel Hinge Domain-Binding Coactivator L7/SPA and the Corepressors N-CoR or SMRT
Open accessAbstract
Steroid receptor antagonists, such as the antiestrogen tamoxifen or the antiprogestin RU486, can have inappropriate agonist-like effects in tissues and tumors. To explain this paradox we postulated that coactivators are inadvertently brought to the promoters of DNA-bound, antagonist-occupied receptors. The human (h) progesterone receptor (PR) hinge-hormone binding domain (H-HBD) was used as bait in a two-hybrid screen of a HeLa cDNA library, in which the yeast cells were treated with RU486. We have isolated and characterized two interesting steroid receptor-interacting proteins that regulate transcription in opposite directions. The first is L7/SPA, a previously described 27-kDa protein containing a basic region leucine zipper domain, having no known nuclear function. When coexpressed with tamoxifen-occupied estrogen receptors (hER) or RU486-occupied hPR or glucocorticoid receptors (hGR), L7/SPA increases the partial agonist activity of the antagonists by 3- to 10-fold, but it has no effect on agonist-mediated transcription. The interaction of L7/SPA with hPR maps to the hinge region, and indeed, the hPR hinge region squelches L7/SPA-dependent induction of antagonist-mediated transcription. Interestingly, pure antagonists that lack partial agonist effects, such as the antiestrogen ICI164,384 or the antiprogestin ZK98299, cannot be up-regulated by L7/SPA. We also isolated, cloned, and sequenced the human homolog (hN-CoR) of the 270-kDa mouse (m) thyroid/retinoic acid receptor corepressor. Binding of hN-CoR maps to the hPR-HBD. mN-CoR, and a related human corepressor, SMRT, suppress RU486 or tamoxifen-mediated partial agonist activity by more than 90%. This suppression is completely squelched by overexpression of the hPR H-HBD. Additionally, both corepressors reverse the antagonist-dependent transcriptional up-regulation produced by L7/SPA. Our data suggest that the direction of transcription by antagonist-occupied steroid receptors can be controlled by the ratio of coactivators to corepressors recruited to the transcription complex by promoter-bound receptors. In normal tissues and in hormone-resistant breast cancers in which the agonist activity of mixed antagonists predominates, steroid receptors may be preferentially bound by coactivators. This suggests a strategy by which such partial agonist activity can be eliminated and by which candidate receptor ligands can be screened for this activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
A novel genetic system to detect protein–protein interactions
Fields, S., & Song, O.-K. (1989) · Nature · doi:10.1038/340245a0 · Cited by 6,114
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,158
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M.-J., & O'Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,932
Schiestl, R. H., & Gietz, R. D. (1989) · Current Genetics · doi:10.1007/bf00340712 · Cited by 2,131
Hörlein, A. J., Näär, A. M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Söderström, M., Glass, C. K., et al. (1995) · Nature · doi:10.1038/377397a0 · Cited by 2,034
Mammalian Ras interacts directly with the serine/threonine kinase raf
Vojtek, A. B., Hollenberg, S. M., & Cooper, J. A. (1993) · Cell · doi:10.1016/0092-8674(93)90307-c · Cited by 1,941
How eukaryotic transcriptional activators work
Ptashne, M. (1988) · Nature · doi:10.1038/335683a0 · Cited by 1,825
Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08280.x · Cited by 1,534
Chien, C. T., Bartel, P. L., Sternglanz, R., & Fields, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9578 · Cited by 1,492
X-Ray Structure of the GCN4 Leucine Zipper, a Two-Stranded, Parallel Coiled Coil
O'Shea, E. K., Klemm, J. D., Kim, P. S., & Alber, T. (1991) · Science · doi:10.1126/science.1948029 · Cited by 1,440
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
Love, R. R., Mazess, R. B., Barden, H. S., Epstein, S., Newcomb, P. A., Jordan, V. C., Carbone, P. P., & DeMets, D. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261302 · Cited by 1,129
Determinants of target gene specificity for steroid/thyroid hormone receptors
Umesono, K., & Evans, R. M. (1989) · Cell · doi:10.1016/0092-8674(89)90051-2 · Cited by 948
Nuclear receptor coactivators and corepressors
Horwitz, K. B. (1996) · Molecular Endocrinology · doi:10.1210/me.10.10.1167 · Cited by 942
Self-citationFunctional dissection of a eukaryotic transcriptional activator protein, GCN4 of Yeast
Hope, I. A., & Struhl, K. (1986) · Cell · doi:10.1016/0092-8674(86)90070-x · Cited by 880
Frangioni, J. V., & Neel, B. G. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1170 · Cited by 879
Webb, P. (1995) · Molecular Endocrinology · doi:10.1210/me.9.4.443 · Cited by 693
Progestin regulation of cellular proliferation.
CLARKE, C. L., & SUTHERLAND, R. L. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-266 · Cited by 650
Turner, R., & Tjian, R. (1989) · Science · doi:10.1126/science.2494701 · Cited by 648
Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist
Damm, K., Thompson, C. C., & Evans, R. M. (1989) · Nature · doi:10.1038/339593a0 · Cited by 579
Polarity-specific activities of retinoic acid receptors determined by a co-repressor
Kurokawa, R., Söderström, M., Hörlein, A., Halachmi, S., Brown, M., Rosenfeld, M. G., & Glass, C. K. (1995) · Nature · doi:10.1038/377451a0 · Cited by 547
Steroid receptors and their associated proteins
Smith, D. F. (1993) · Molecular Endocrinology · doi:10.1210/me.7.1.4 · Cited by 545
Katzenellenbogen, J. A. (1996) · Molecular Endocrinology · doi:10.1210/me.10.2.119 · Cited by 535
A novel genetic system to detect protein-protein interactions
Chien, C. (1991) · Proceedings of the National Academy of Sciences · Cited by 532
Kedar, R., Bourne, T. H., Collins, W. P., Campbell, S., Powles, T. J., Ashley, S., & Cosgrove, D. O. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92466-x · Cited by 531
Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens
McDonnell, D. P. (1995) · Molecular Endocrinology · doi:10.1210/me.9.6.659 · Cited by 526
Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary Malignancies
Rutqvist, L. E., Johansson, H., Signomklao, T., Johansson, U., Fornander, T., & Wilking, N. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.9.645 · Cited by 508
Lee, J. W. (1995) · Molecular Endocrinology · doi:10.1210/me.9.2.243 · Cited by 447
Gietz, R. D., & Schiestl, R. H. (1991) · Yeast · doi:10.1002/yea.320070307 · Cited by 437
Yang, N. N., Venugopalan, M., Hardikar, S., & Glasebrook, A. (1996) · Science · doi:10.1126/science.273.5279.1222 · Cited by 429
Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA
Misrahi, M., Atger, M., d'Auriol, L., Loosfelt, H., Meriel, C., Fridlansky, F., Guiochon-Mantel, A., Galibert, F., & Milgrom, E. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)91416-1 · Cited by 418
Seol, W. (1995) · Molecular Endocrinology · doi:10.1210/me.9.1.72 · Cited by 393
Sap, J., Muñoz, A., Schmitt, J., Stunnenberg, H., & Vennström, B. (1989) · Nature · doi:10.1038/340242a0 · Cited by 378
Vegeto, E., Allan, G. F., Schrader, W. T., Tsai, M.-J., McDonnell, D. P., & O'Malley, B. W. (1992) · Cell · doi:10.1016/0092-8674(92)90234-4 · Cited by 377
Allan, G. F., Leng, X., Tsai, S. Y., Weigel, N. L., Edwards, D. P., Tsai, M. J., & O'Malley, B. W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41805-4 · Cited by 355
Danielsen, M., Hinck, L., & Ringold, G. M. (1989) · Cell · doi:10.1016/0092-8674(89)90050-0 · Cited by 354
Sartorius, C. A. (1994) · Molecular Endocrinology · doi:10.1210/me.8.10.1347 · Cited by 342
Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor.
Meyer, M. E., Pornon, A., Ji, J. W., Bocquel, M. T., Chambon, P., & Gronemeyer, H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07613.x · Cited by 328
Tung, L., Mohamed, M. K., Hoeffler, J. P., Takimoto, G. S., & Horwitz, K. B. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.10.8123133 · Cited by 324
Self-citationBocquel, M. T., Kumar, V., Stricker, C., Chambon, P., & Gronemeyer, H. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.7.2581 · Cited by 292
Baniahmad, A., Leng, X., Burris, T. P., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.76 · Cited by 249
Adler, S., Waterman, M. L., He, X., & Rosenfeld, M. G. (1988) · Cell · doi:10.1016/0092-8674(88)90406-0 · Cited by 227
HORWITZ, K. B. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-146 · Cited by 221
Self-citationSartorius, C. A., Groshong, S. D., Miller, L. A., Powell, R. L., Tung, L. W., Takimoto, G. S., & Horwitz, K. B. (1994) · PubMed · Cited by 212
Self-citationBeck, C. A., Weigel, N. L., Moyer, M. L., Nordeen, S. K., & Edwards, D. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4441 · Cited by 205
Second Cancers After Adjuvant Tamoxifen Therapy for Breast Cancer
Curtis, R. E., Boice, J. D., Shriner, D. A., Hankey, B. F., & Fraumeni, J. F. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.12.832 · Cited by 181
Sartorius, C. A., Tung, L., Takimoto, G. S., & Horwitz, K. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98344-4 · Cited by 176
Self-citationKlein-Hitpass, L., Cato, A. C. B., Henderson, D., & Ryffel, G. U. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.6.1227 · Cited by 176
Lykkesfeldt, A. E., Madsen, M. W., & Briand, P. (1994) · PubMed · Cited by 160
Jordan, V. C. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00713399 · Cited by 150
Fan, J. D., Wagner, B. L., & McDonnell, D. P. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.12.8961270 · Cited by 139
Fujimoto, N., & Katzenellenbogen, B. S. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.3.7517003 · Cited by 124
Takimoto, G. S., Tasset, D. M., Eppert, A. C., & Horwitz, K. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3050 · Cited by 113
Self-citationAllan, G. F., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.11750 · Cited by 106
Structural and functional properties of ribosomal protein L7 from humans and rodents
Hemmerich, P. H., von Mikecz, A. H., Neumann, F., Sözeri, O., Wolff-Vorbeck, G., Zoebelein, R., & Krawinkel, U. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.2.223 · Cited by 82
Tong, G., Jeyakumar, M., Tanen, M. R. L., & Bagchi, M. K. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.1909 · Cited by 49
Neumann, F., Hemmerich, P. H., von Mikecz, A. H., Peter, H. H., & Krawinkel, U. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.2.195 · Cited by 49
Mizuta, K., Hashimoto, T., & Otaka, E. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.5.1011 · Cited by 35
Combined effects of RU486 and tamoxifen on the growth and cell cycle phases of the MCF-7 cell line
Thomas, M., & Monet, J.-D. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.3.865 · Cited by 33
(1994) · Endocrine Related Cancer · doi:10.1677/erc.0.0010005 · Cited by 26
Cited by
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0002 · Cited by 4,585
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Estrogen receptors: how do they signal and what are their targets
Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Ström, A., Treuter, E., Warner, M., et al. (2007) · Physiological Reviews · doi:10.1152/physrev.00026.2006 · Cited by 1,857
Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription
Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., & Brown, M. (2000) · Cell · doi:10.1016/s0092-8674(00)00188-4 · Cited by 1,657
Metadata
- Authors
- Jackson, T. A., Richer, J. K., Bain, D. L., Takimoto, G. S., Tung, L. W., & Horwitz, K. B.
- Venue
- Molecular Endocrinology
- Publisher
- Oxford University Press
- Published
- 1997-06-01
- Volume
- 11
- Issue
- 6
- Pages
- 693-705
- ISSN
- 0888-8809 (ISSN-L)
- OpenAlex
- W1990342690
- Cited by
- 478
- References
- 61
- FWCI
- 22.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.